Ally Bridge Group
Status
ACTIVE
Global HQ
Hong Kong Island, Hong Kong
Countries of investment
- USA
- China
Investment stages
- Seed
- Series A
- Series B
Industries
- Biotechnology
- Health Tech
- AI
About
Ally Bridge Group is a global healthcare investment management firm focused on highimpact life science innovation. The firm was founded in 2013 by Frank Yu, who serves as Chief Executive Officer and Chief Investment Officer. It has managed over $6 billion in transactions across healthcare subsectors, with the mission to generate superior riskadjusted returns for investors while addressing unmet medical needs through the blend of scientific research and capital markets expertise. Ally Bridge Group operates from offices in New York and Hong Kong and invests in both private and public equity in the healthcare industry.
Ally Bridge Group is a global healthcare investment management firm focused on highimpact life science innovation. The firm was founded in 2013 by Frank Yu, who serves as Chief Executive Officer and Chief Investment Officer. It has managed over $6 billion in transactions across healthcare subsectors, with the mission to generate superior riskadjusted returns for investors while addressing unmet medical needs through the blend of scientific research and capital markets expertise. Ally Bridge Group operates from offices in New York and Hong Kong and invests in both private and public equity in the healthcare industry.
Investment Thesis
Ally Bridge Group focuses on highimpact life science innovation, investing across the global healthcare industry to address unmet medical needs while generating superior riskadjusted returns.